Company / Operating Margin
CAPRICOR THERAPEUTICS, INC. Operating Margin History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-191.1%
FY2024
5-year range
-8549.9% / -95.6%
FY2020-FY2024
Trend
-99.9%
vs FY2023
Sector context
#98 of 136
Health Care
What the data says
At -191.1%, CAPRICOR THERAPEUTICS, INC.'s operating margin ranks #98 of 136 in the Health Care sector. Improved from -1163.9% to -191.1% over the past 2 years.
Based on SEC 10-K filings.
-191.1% in FY2024 with a 5-year CAGR of +725.9%.
Improved from -1163.9% to -191.1% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +8358.7pp
- 5-Year Change
- +725.9pp
- 10-Year Change
- -
Sector benchmark
#98 of 136 in Health CareTop 72% of 136This company -191.1% Sector average -778.9%
▼
+75.5% above sector average
Key checks
Key Insights
- In FY2024, operating margin decreased 99.9% year-over-year.
- Currently 587.8pp above the Health Care sector average.
- Peak operating margin was recorded in FY2023.
- Lowest operating margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -191.1% | -99.9% |
| FY2023 | -95.6% | +91.8% |
| FY2022 | -1163.9% | +86.4% |
| FY2021 | -8549.9% | -93.8% |
| FY2020 | -4412.6% | -381.2% |
| FY2019 | -917.0% | +0.0% |
| FY2018 | -917.0% | -90.1% |
| FY2017 | -482.4% | -13.6% |
| FY2016 | -424.6% | -85.7% |
As of FY2024 · SEC 10-K · Updated Jul 4, 2026